These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

684 related items for PubMed ID: 25430888

  • 1. CUL4B activates Wnt/β-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists.
    Yuan J, Han B, Hu H, Qian Y, Liu Z, Wei Z, Liang X, Jiang B, Shao C, Gong Y.
    J Pathol; 2015 Apr; 235(5):784-95. PubMed ID: 25430888
    [Abstract] [Full Text] [Related]

  • 2. CUL4B: a novel epigenetic driver in Wnt/β-catenin-dependent hepatocarcinogenesis.
    Mok MT, Cheng AS.
    J Pathol; 2015 May; 236(1):1-4. PubMed ID: 25664533
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma.
    Zhang D, Ma X, Sun W, Cui P, Lu Z.
    Int J Clin Exp Pathol; 2015 May; 8(3):3386-94. PubMed ID: 26045876
    [Abstract] [Full Text] [Related]

  • 7. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y, Jiang L, Hu Y, Xiao C, Xu N, Zhou J, Zhou X.
    BMC Cancer; 2017 Feb 28; 17(1):161. PubMed ID: 28241806
    [Abstract] [Full Text] [Related]

  • 8. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
    He YM, Xiao YS, Wei L, Zhang JQ, Peng CH.
    J Cell Biochem; 2018 Jul 28; 119(7):5308-5323. PubMed ID: 29274277
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
    Quan H, Zhou F, Nie D, Chen Q, Cai X, Shan X, Zhou Z, Chen K, Huang A, Li S, Tang N.
    Oncogene; 2014 May 29; 33(22):2826-35. PubMed ID: 23770846
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.
    Jiang N, Chen WJ, Zhang JW, Xu C, Zeng XC, Zhang T, Li Y, Wang GY.
    Oncotarget; 2015 Apr 10; 6(10):7866-79. PubMed ID: 25797263
    [Abstract] [Full Text] [Related]

  • 12. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
    Tsao CM, Yan MD, Shih YL, Yu PN, Kuo CC, Lin WC, Li HJ, Lin YW.
    Hepatology; 2012 Dec 10; 56(6):2277-87. PubMed ID: 22767186
    [Abstract] [Full Text] [Related]

  • 13. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
    Wu Y, Li J, Sun CY, Zhou Y, Zhao YF, Zhang SJ.
    Neoplasma; 2012 Dec 10; 59(3):326-32. PubMed ID: 22296502
    [Abstract] [Full Text] [Related]

  • 14. DKK1 promotes hepatocellular carcinoma cell migration and invasion through β-catenin/MMP7 signaling pathway.
    Chen L, Li M, Li Q, Wang CJ, Xie SQ.
    Mol Cancer; 2013 Dec 10; 12():157. PubMed ID: 24325363
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Knockdown of CUL4B inhibits proliferation and promotes apoptosis of colorectal cancer cells through suppressing the Wnt/β-catenin signaling pathway.
    Song B, Zhan H, Bian Q, Li J.
    Int J Clin Exp Pathol; 2015 Dec 10; 8(9):10394-402. PubMed ID: 26617747
    [Abstract] [Full Text] [Related]

  • 17. Effect and mechanism of miR-217 on drug resistance, invasion and metastasis of ovarian cancer cells through a regulatory axis of CUL4B gene silencing/inhibited Wnt/β-catenin signaling pathway activation.
    Liu HR, Zhao J.
    Eur Rev Med Pharmacol Sci; 2021 Jan 10; 25(1):94-107. PubMed ID: 33506897
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
    Zhao R, Wang N, Huang H, Ma W, Yan Q.
    Liver Int; 2014 Jul 10; 34(6):e151-60. PubMed ID: 24529164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.